← Back to Clinical Trials
Recruiting NCT07116291

NCT07116291 Impact of Regular Karate Practice on the Quality of Life and Health Outcomes of Students

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07116291
Status Recruiting
Phase —
Sponsor University Hospital, Angers
Condition Medical Student
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-09-04
Primary Completion 2026-07-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Karate

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-09-04 with a primary completion date of 2026-07-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A recent study reported that 52% of medical students had an anxiety disorder and 18% had a depressive syndrome. Following this publication, the Inspectorate General of Social Affairs commissioned a report on the quality of life of health students, making it a health priority. One of the causes of the malaise felt by students could be the stress associated with exams and recent reforms. This malaise could also be due to a drop in self-esteem linked to the environment and atmosphere on certain placement sites. In fact, one of our recent studies suggested that the quality of life of doctors in the clerkship could influence the quality of life of students. Since self-esteem is an important parameter in a student's understanding of his or her academic career, improving self-esteem could improve academic results and the quality of life of students. Among the martial arts evaluated, karate has shown promising results in improving concentration and regulating the feelings of child victims of war in particular, as well as the elderly. Karate could therefore be a simple and effective solution for improving the mental health of healthy students, as well as their academic results. As it is a sport considered to be of moderate intensity, particularly through the practice of kat, it can be practised by anyone without contraindication apart from coronary artery disease.

Eligibility Criteria

Inclusion Criteria: * 3rd or 4th year health students at the university of Angers Exclusion Criteria: * contraindication to the practice of karate * students repeating a year or entering the third year after a transfer, insofar as the evolution of their grades in relation to the 2nd year class cannot be ascertained. * Students who already practise karate regularly cannot be included. * Students planning to transfer to another faculty during the year of study

Contact & Investigator

Central Contact

Aurélien VENARA

✉ aurelien.venara@chu-angers.fr

📞 241353637

Principal Investigator

Aurélien VENARA, MD-PhD

PRINCIPAL INVESTIGATOR

University Hospital, Angers

Frequently Asked Questions

Who can join the NCT07116291 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Medical Student. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07116291 currently recruiting?

Yes, NCT07116291 is actively recruiting participants. Contact the research team at aurelien.venara@chu-angers.fr for enrollment information.

Where is the NCT07116291 trial being conducted?

This trial is being conducted at Angers, France.

Who is sponsoring the NCT07116291 clinical trial?

NCT07116291 is sponsored by University Hospital, Angers. The principal investigator is Aurélien VENARA, MD-PhD at University Hospital, Angers. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology